Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease: Relation to Endothelium-Dependent Vasodilation
暂无分享,去创建一个
D. Harrison | H. Drexler | U. Landmesser | B. Hornig | S. Dikalov | S. Spiekermann | M. Bredt | H. Tatge | Graciela Gamez | Nina Reepschläger
[1] R. Busse,et al. Endothelium-Derived Hyperpolarizing Factor Synthase (Cytochrome P450 2C9) Is a Functionally Significant Source of Reactive Oxygen Species in Coronary Arteries , 2001, Circulation research.
[2] J. Keaney,et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1999, Circulation.
[3] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.
[4] S. Marklund,et al. Binding of Xanthine Oxidase to Vascular Endothelium , 1999, The Journal of Biological Chemistry.
[5] K. Channon,et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. , 2000, Circulation research.
[6] G. Levine,et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.
[7] U. Ryan,et al. Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. , 1992, The Journal of clinical investigation.
[8] B. Fink,et al. Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C. , 1999, Free radical biology & medicine.
[9] A M Zeiher,et al. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.
[10] H. Drexler,et al. Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease: Role of Superoxide Dismutase , 2001, Circulation.
[11] D. Harrison,et al. Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.
[12] H. Drexler,et al. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.
[13] Y. Hayashi,et al. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. , 1999, Circulation.
[14] S. Vickers,et al. Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane. , 1998, Surgery.
[15] W. R. Taylor,et al. Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis , 2002, Circulation.
[16] M. Benboubetra,et al. A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donor. , 1998, Free radical research.
[17] D. Harrison,et al. Oxidative stress and vascular damage in hypertension , 2001, Coronary artery disease.
[18] A. Quyyumi,et al. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. , 1997, Hypertension.
[19] A. Bindoli,et al. Antioxidant properties of clozapine and related neuroleptics. , 1998, Free radical research.
[20] T. Meinertz,et al. Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.
[21] D. Harrison,et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. , 1999, Circulation.
[22] H. Drexler,et al. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. , 2000, Circulation.
[23] Friedrich C. Luft,et al. Endothelial Dysfunction and Xanthine Oxidoreductase Activity in Rats With Human Renin and Angiotensinogen Genes , 2001, Hypertension.
[24] B. Fink,et al. A new approach for extracellular spin trapping of nitroglycerin-induced superoxide radicals both in vitro and in vivo. , 2000, Free radical biology & medicine.
[25] K. Hirano,et al. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. , 1993, The Biochemical journal.
[26] E. Bassenge,et al. Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-2,2,6, 6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants. , 1997, Biochemical and biophysical research communications.
[27] J A Thompson,et al. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] D. Harrison,et al. Oxidant stress as a marker for cardiovascular events: Ox marks the spot. , 2001, Circulation.
[29] J. Mehta,et al. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. , 1994, Circulation.
[30] F. Stirpe,et al. The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). , 1969, The Journal of biological chemistry.
[31] D. Tosh,et al. Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture , 1998, FEBS letters.